��躰�肽𨯙嚙踝蕭�椬��㮖����𠺪蕭��辷蕭
��躰�頣蕭皛抵�䈑蕭嚙踝蕭膌见�躰�肽𨯙
��躰�肽𨯙嚙踝蕭颲瑁𨯙�𢥫嚙質�嚙踢�𧶏蕭薳��𨯙
��躰釭嚙賢��𨯙嚙賡ㄤ��躰釭嚙賭�對蕭嚙�
��躰釭嚙賢��𨯙嚙踝蕭蒺矋蕭嚙賣���辷蕭
��躰�頣蕭嚙質𨯙��鞱�矋蕭��躰�肽𨯙嚙踢岡芾働嚙�
��躰�頣蕭皛抵�䈑蕭嚙踝蕭嚙賢�磰𨯙嚙踢﹜���躰�肽𨯙��躰�肽𨯙
嚙賭麩��躰�肽𨯙嚙賭�𡑒𨯙��躰�肽𨯙��躰�肽𨯙
��躰腺鈭�䁥滩𨯙嚙賡�嚙踝蕭��躰�頣蕭�迚�𨯙
��躰�肽𨯙嚙踝蕭嚙踢�佅嚙賢�躰�肽𨯙嚙踝蕭�迚�𨯙
��躰�肽𨯙嚙賜�嚙踝蕭臐�鳴蕭�莎蕭撠𩤃蕭臐�航𨯙��躰郭嚙踢岸��𨯙��辷蕭
��躰�肽𨯙��躰�肽𨯙嚙賡做嚙踢╱ｇ蕭暻芸�躰腺�𧊋臐�航𨯙��躰�肽𨯙
嚙踝蕭��嚙質�磰𨯙��躰�肽𨯙嚙賢䐓��躰釭臐�嚙踝蕭嚙踝蕭��辷蕭
��躰釭嚙賢��𨯙嚙踢�鍦�躰�栶�笔�辷蕭
��躰都嚙賢�躰腺嚙賬���躰腺嚙賢��
��躰酗��𥕦�躰郭��嚙賢��𨯙��鮋ㄙ
��躰都嚙賢�躰腺嚙賬���躰�肽𨯙��躰�肽𨯙��辷蕭
��躰都嚙賢�躰腺嚙賬�嚙踝蕭嚙質𨯙��躰�肽𨯙
��躰酗藆�坿���嚙質�𨅯�𡑒��𨯙��辷蕭
��躰酗��𨥈蕭嚙踢�航𨯙嚙踝蕭嚙踝蕭臐��𨯙
嚙踢坎萘���朞𨯙�坾蝞�嚙賢�躰�肽𨯙��辷蕭
��躰閉瘣賢�躰酗嚙踢�航𨯙�����𨯙��辷蕭
嚙踢△�嚙踝蕭嚙質𨯙嚙踝蕭璇寡𨯙��辷蕭
��躰�肽𨯙��躰腺銝滚��𨯙��躰�肽𨯙��躰�肽𨯙
��躰�肽𨯙��𥕦�页蕭���𧒆䕘蕭薴ㄟ��躰腺��舘�舘𨯙
��躰腺鈭�䁥滩𨯙嚙賡�嚙踢�𦴣��躰�肽𨯙��躰�肽𨯙
��躰閉�蕟��躰�肽𨯙��嚙踝蕭�𨯙��琜蕭藃�讛𨯙��辷蕭
嚙踝蕭薳閦�𥕦�𩤃蕭嚙質𨯙��躰�肽𨯙��躰�肽𨯙
嚙踝蕭薳閦�𥕦�𩤃蕭嚙質𨯙��躰部薴钟��辷蕭
��躰腺嚙賣�坿𨯙��嚙賣Ⅰ�𨯙��躰�肽𨯙��辷蕭
��躰腺嚙賣�坿𨯙��嚙賜�橘蕭嚙質�芷礆嚙�
嚙踝蕭臐号艟洽嚙踝蕭��磰𨯙��躰�肽𨯙��辷蕭
��躰�肽𨯙嚙賢𠘕嚙賢𠹭��㚁蕭銧游�辷蕭
��躰�肽𨯙��𥟇䠋�𨯙��躰�肽𨯙��𥪮�航𨯙
嚙踝蕭�緾嚙賢�躰郭嚙賭�𡑒𨯙嚙踝蕭嚙�
��躰�肽𨯙嚙踢╱Ｚ躀臐��𨯙��躰�肽𨯙��辷蕭
嚙踝蕭艟妟��𥕦�躰郭嚙賭�𤏸𨯙��躰�肽𨯙��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭嚙踝蕭�佞𧒆��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭擗�𠯫�𧒆��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭憍辷蕭�莎蕭嚙質鷄嚙踝蕭
��躰�肽𨯙��𥕦��𨯙嚙賜�皜脩腦嚙踢𧒆��辷蕭
��躰�肽𨯙��𥕦��𨯙嚙賜�皜賂蕭�樹𧒆��辷蕭
嚙踝蕭艟妟��𥕦�躰釭�𡁜�躰腺嚙踝蕭藂��𨯙��躰釭蝮�蕭�𧒆��辷蕭
嚙踝蕭艟妟��𥕦�躰釭�𡁜�躰腺嚙踝蕭藂��𨯙��躰郭嚙賜�樹𧒆��辷蕭
��躰腺�亙�滩𨯙��躰�頣蕭��𡏭𨯙��躰�肽𨯙�����痹蕭嚙�
��躰�肽𨯙嚙踢𧒆䕘蕭嚙踢孜讛𨯙��躰�肽𨯙��辷蕭
嚙踝蕭���蕭�䁥滩𨯙��琜蕭�迚�𨯙��辷蕭
��躰�肽𨯙��躰郭�𨺗��躰�肽𨯙
��躰�肽𨯙��躰�肽𨯙嚙踝蕭隤抵���嚙賬答�𨯙��躰�肽𨯙
巨漢(6903)
月營收
季盈餘
2025/03/01
117.5元 (巨漢股價)
2025/03/01
-49.66%
(年增率)
175百萬元 (營收)
巨漢(6903) 年度營收走勢圖
巨漢(6903)月營收明細
單位：仟元
年/月
營收
月增率
去年同期
年增率
累計營收
年增率
114/03
174,684
24.48%
347,024
-49.66%
419,832
-48.15%
114/02
140,326
33.87%
260,056
-46.04%
245,148
-47.01%
114/01
104,822
-56.01%
202,573
-48.25%
104,822
-48.25%
113/12
238,269
37.62%
270,468
-11.90%
2,886,347
0.64%
113/11
173,136
13.48%
207,452
-16.54%
2,648,078
1.95%
113/10
152,570
-25.36%
207,486
-26.47%
2,474,942
3.55%
113/09
204,418
21.40%
253,259
-19.29%
2,322,372
6.41%
113/08
168,387
-16.76%
187,462
-10.18%
2,117,954
9.78%
113/07
202,288
-21.03%
229,028
-11.68%
1,949,567
11.93%
113/06
256,162
-31.26%
251,560
1.83%
1,747,279
15.50%
113/05
372,651
20.67%
196,167
89.97%
1,491,117
18.23%
113/04
308,813
-11.01%
236,117
30.79%
1,118,466
5.01%
113/03
347,024
33.44%
221,870
56.41%
809,653
-2.33%
113/02
260,056
28.38%
243,931
6.61%
462,629
-23.79%
113/01
202,573
-25.10%
363,138
-44.22%
202,573
-44.22%
112/12
270,468
30.38%
274,007
-1.29%
2,867,938
-39.20%
112/11
207,452
-0.02%
272,596
-23.90%
2,597,470
-41.54%
112/10
207,486
-18.07%
479,590
-56.74%
2,390,018
-42.69%
112/09
253,259
35.10%
209,857
20.68%
2,182,532
-40.87%
112/08
187,462
-18.15%
302,403
-38.01%
1,929,273
-44.58%
112/07
229,028
-8.96%
490,625
-53.32%
1,741,811
-45.20%
112/06
251,560
28.24%
634,385
-60.35%
1,512,783
-43.72%
112/05
196,167
-16.92%
584,294
-66.43%
1,261,223
-38.59%
112/04
236,117
6.42%
546,532
-56.80%
1,065,056
-27.52%
112/03
221,870
-9.04%
371,039
-40.20%
828,939
-10.18%
112/02
243,931
-32.83%
267,005
-8.64%
607,069
10.01%
112/01
363,138
32.53%
284,843
27.49%
363,138
27.49%
111/12
274,007
0.52%
483,333
-43.31%
4,717,176
78.19%
111/11
272,596
-43.16%
246,156
10.74%
4,443,169
109.87%
111/10
479,590
128.53%
239,191
100.51%
4,170,573
122.92%
111/09
209,857
-30.60%
152,406
37.70%
3,690,983
126.20%
111/08
302,403
-38.36%
111,762
170.58%
3,481,126
135.32%
111/07
490,625
-22.66%
32,565
1,406.60%
3,178,723
132.44%
111/06
634,385
8.57%
150,801
320.68%
2,688,098
101.36%
111/05
584,294
6.91%
287,894
102.95%
2,053,713
73.43%
111/04
546,532
47.30%
1,469,419
111/03
371,039
38.96%
922,887
111/02
267,005
-6.26%
551,848
111/01
284,843
-41.07%
284,843
110/12
483,333
96.35%
2,647,333
110/11
246,156
2.91%
2,117,055
110/10
239,191
56.94%
1,870,899
110/09
152,406
36.37%
1,631,708
110/08
111,762
243.20%
1,479,302
110/07
32,565
-78.41%
1,367,540
110/06
150,801
-47.62%
1,334,976
110/05
287,894
1,184,175
110/04
說明：自2013年起上市櫃公司因IFRSs會計準則規範，每月公告的營收必須是合併營收，不再公告非合併營收。2012年(含)前，合併營收是採自願公告。
